Document:

Exhibit 10.1

 

CONSULTING AGREEMENT

 

I.                                        GENERAL INFORMATION

 

	
Effective Date:
    	
 
    	
August 2, 2019
    
	
Company Name and Address:
    	
 
    	
Quanterix Corporation
   900 Middlesex Turnpike
   Billerica, Massachusetts 01821
    
	
Consultant Name and Address:
    	
 
    	
Jackson Streeter, MD
   [***]
    
	
Quanterix Contact:
    	
 
    	
Mark Roskey, Senior Vice President, Commercial and   Assays
    
	
Agreement Term:
    	
 
    	
Through November 30, 2019
    

 

II.

 

This Consulting Agreement (“Agreement”) is made as of the Effective Date by and between the Company and the Consultant. The Company desires to retain Consultant to perform consulting services for the Company and Consultant is willing to perform such services, on terms set forth more fully in this Agreement.

 

This Agreement consists of this cover page and the following Exhibits:

 

·                  Exhibit 1 — General Terms and Conditions

·                  Exhibit 2 — Statement of Work

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the Effective Date.

 

	
QUANTERIX CORPORATION
    	
 
    	
CONSULTANT
    
	
 
    	
 
    	
 
    
	
/s/ Mark Roskey
    	
 
    	
/s/ Jackson Streeter,   MD
    
	
Name: 
    	
Mark Roskey
    	
 
    	
Name: 
    	
Jackson Streeter, MD
    
	
Title: 
    	
Senior Vice President,   Commercial
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
Date:
    	
July 31, 2019
    	
 
    	
Date:
    	
July 31, 2019
    
	
 
    	
 
    	
 
    	
 
    	
 
    

 

Portions of this Exhibit, indicated by the mark “[***],” were omitted because the information (i) is not material and (ii) would be competitively harmful if publicly disclosed.

 

1

 

Consulting Agreement

Exhibit A — General Terms and Conditions

 

In consideration of the mutual promises contained herein, the parties agree as follows:

 

1.                                      SERVICES AND COMPENSATION

 

During the Term, Consultant agrees to perform the services requested by the Company, including the duties and tasks described in Exhibit A (the “Services”). Consultant agrees to devote such time as Consultant and the Company agree are necessary to perform the Services.

 

The Quanterix Contact, or such other person as may be designated by the Quanterix Contact from time-to-time, will be Consultant’s principal point of contact within Quanterix. The Consultant will render such services, and provide reports and other information, as may be requested by the Quanterix Contact.

 

The Company agrees to pay Consultant the compensation set forth in Exhibit A as compensation for the performance of the Services.

 

Except as otherwise requested by the Quanterix Contact, the Consultant shall submit reasonable documentation of the Services outlined in Exhibit B. Quanterix will, subject to the prior written approval of the Quanterix Contact, and subject to Quanterix’ then-current travel and expense reimbursement policies, reimburse Consultant’s actual out-of-pocket expenses incurred in connection with this Agreement. The Consultant will provide such receipts or other documentation as may be requested by the Company to document such expenses.

 

The Company will pay the Consultant within thirty (30) days of receipt of Consultant’s invoice.

 

2.                                      CONFIDENTIALITY

 

“Confidential Information” means all information furnished by the Company to Consultant, regardless of whether such information is specifically designated as confidential and regardless of whether such information is in written, oral, electronics, or other form. Information which is not marked confidential at the time of disclosure (or identified as such if disclosed verbally) shall be considered confidential if a reasonable person would understand such information to be Confidential Information of Company. Confidential Information may include, but is not limited to: (a) corporate information, including plans, strategies, methods, policies, resolutions, negotiations or litigation; (b) marketing information, including strategies, methods, customer identities or other information about customers, prospect identities or other information about prospects, or market analyses or projections; (c) financial information, including cost and performance data, debt arrangements, equity structure, investors and holdings, purchasing and sales data and price lists; and (d) operational and technological information, including plans, specifications, manuals, forms, templates, software, designs, methods, procedures, formulas, discoveries, inventions, improvements, concepts and ideas; and (e) personnel information, including personnel lists, reporting or organizational structure, resumes, personnel data, compensation structure, performance evaluations and termination arrangements or documents. Confidential Information also includes information received by the Company from its customers or suppliers or other third parties.

 

Consultant will not, at any time, without the Company’s prior written permission, either during or after the term of this Agreement, disclose any Confidential Information to anyone outside of the Company, or use or permit to be used any Confidential Information for any purpose other than the performance of the Services for or on behalf of the Company. Consultant will cooperate with the Company and use best efforts to prevent the unauthorized disclosure or use of any and all Confidential Information. Consultant will deliver to the Company all copies of Confidential Information in Consultant’s possession or control upon the earlier of a request by the Company or termination of this Agreement for any reason.

 

Consultant understands that the Company is now and may hereafter be subject to non-disclosure or confidentiality agreements with third persons which require the Company to protect or refrain from use of Confidential Information. Consultant agrees to be bound by the terms of such agreements in the event Consultant has access to such Confidential Information.

 

The confidentiality obligations in this Agreement shall not apply to information that Consultant can demonstrate: (i) was at the time of disclosure already in the public domain or becomes available to the public other than as a result of a breach of this Agreement by the Consultant; (ii) was in the lawful possession of the Consultant, without an obligation of confidentiality or restriction on use, prior to receipt from the Discloser; (iii) was received by the Consultant on a non-confidential basis from a source other than the Discloser and the Consultant reasonably believed that such source was not bound by an agreement of confidentiality with the Quanterix; or (iv) was subsequently independently developed by the Consultant, without use of the Confidential Information of the Discloser.

 

Portions of this Exhibit, indicated by the mark “[***],” were omitted because the information (i) is not material and (ii) would be competitively harmful if publicly disclosed.

 

2

 

3.                                      INTELLECTUAL PROPERTY

 

Consultant will make full and prompt disclosure to the Company of all inventions, discoveries, designs, developments, methods, modifications, improvements, processes, algorithms, databases, computer programs, formulae, techniques, trade secrets, graphics or images, and written, audio or visual works and other works of authorship (collectively “Developments”), whether or not patentable or copyrightable, that are created, made, conceived or reduced to practice by Consultant (alone or jointly with others) or under Consultant’s direction during the term of this Agreement which are directly related to the Services. Consultant acknowledges that all work performed by Consultant is on a “work for hire” basis, and Consultant hereby assigns and transfers and, to the extent any such assignment cannot be made at present, will assign and transfer, to the Company and its successors and assigns all Consultant’s right, title and interest in all Developments that (a) relate to the Services or otherwise to Consultant’s activities hereunder; or (b) result from the use of premises or personal property (whether tangible or intangible) owned, leased or contracted for by the Company (“Company-Related Developments”), and all related patents, patent applications, trademarks and trademark applications, copyrights and copyright applications, and other intellectual property rights in all countries and territories worldwide and under any international conventions (“Intellectual Property Rights”). Consultant also hereby waives all claims to any moral rights or other special rights which Consultant may have or accrue in any Company-Related Developments. Notwithstanding the foregoing, and for purposes of absolute clarity, any and all inventions, discoveries, designs, developments, methods, modifications, improvements, processes, algorithms, databases, computer programs, formulae, techniques, trade secrets, graphics or images, and written, audio or visual works and other works of authorship, whether or not patentable or copyrightable, that are created, made, conceived or reduced to practice by Consultant (alone or jointly with others) or under Consultant’s direction during the term of this Agreement which do not directly relate to the Services, or which relate to Consultants services to a third party (collectively, the “Consultants Inventions”), all Consultant’s right, title and interest in such Consultants Inventions shall be that of Consultant, or such other third party whom Consultant performed the services if under similar obligations to assign.

 

Consultant will cooperate fully with the Company, and be reasonably compensated therefor, both during and after the term of this Agreement, with respect to the procurement, maintenance and enforcement of Intellectual Property Rights in Company-Related Developments. Consultant will sign, both during and after the term of this Agreement, all papers, including without limitation copyright applications, copyright, patent or other assignments, patent applications, declarations, oaths, assignments of priority rights, and powers of attorney, which the Company may deem necessary or desirable in order to protect its rights and interests in any Company-Related Development. If the Company is unable, after reasonable effort, to secure Consultant’s signature on any such papers, Consultant hereby irrevocably designates and appoints each current and future officer of the Company as Consultant’s agent and attorney-in-fact to execute any such papers on Consultant’s behalf, and to take any and all actions as the Company may deem necessary or desirable in order to protect its rights and interests in any Company-Related Development.

 

4.                                      CONFLICTING OBLIGATIONS; NON-COMPETITION.

 

Consultant represents and warrants that Consultant has no outstanding agreement or obligation that is in conflict with any of the provisions of this Agreement, or that would preclude Consultant from fully complying with the provisions hereof, and further certifies that Consultant will not enter into such conflicting agreement during the term of this Agreement.

 

Consultant further agrees during the Term not to perform any work, either as consultant, contractor, salaried employee, or unpaid advisor, for any of the following companies during the course of the assignment with Quanterix: [***]. In addition, Consultant agrees to inform Company if offered any such work from any other company during the Term which Company could reasonably construe to be a competitor.

 

5.                                      COMPLIANCE WITH LAW AND QUANTERIX’S CODE OF CONDUCT AND ETHICS

 

Consultant will comply with all applicable laws, regulations and ordinances in connection with the Services and this Agreement, including but not limited to laws and regulations relating to interactions with healthcare providers (including but not limited to the Sunshine Act and Medicare fraud and abuse), the Foreign Corrupt Practices Act, and their local or non-US equivalents. Consultant further agrees to comply with the Quanterix Corporation Code of Conduct and Ethics, a copy of which is available at www.quanterix.com.

 

Portions of this Exhibit, indicated by the mark “[***],” were omitted because the information (i) is not material and (ii) would be competitively harmful if publicly disclosed.

 

3

 

6.                                      TERM AND TERMINATION

 

This Agreement will commence on the Effective Date, and will continue until the earlier to occur of: (i) expiration of the Agreement Term; (ii) termination or discontinuation of the Services; or (iii) termination as provided below. The Company and Consultant may extend the term of this Agreement upon mutual agreement.

 

Either party may terminate this Agreement for convenience upon seven (7) days prior written notice thereof to the other party.

 

Either party may terminate this Agreement if the other materially breaches this Agreement, and such breach is incapable of cure, or with respect to a material breach capable of cure, the defaulting party does not cure such breach within thirty (30) days after receipt of written notice of such breach.

 

Expiration or termination of this Agreement will not affect any obligations accrued as of the date of termination.

 

Sections 2 (Confidentiality), 3 (Intellectual Property), 4 (Conflicting Obligations), 6 (Independent Contractors; No Agency), 7 (Equitable Relief), and 8 (Severability) shall survive termination or expiration of this Agreement.

 

7.                                      INDEPENDENT CONTRACTOR; NO AGENCY

 

Nothing in this Agreement shall in any way be construed to constitute Consultant as an agent, employee or representative of the Company, but Consultant shall perform the Services hereunder as an independent contractor. Consultant acknowledges and agrees that Consultant is obligated to report as income all compensation received by Consultant pursuant to this Agreement, and Consultant agrees to and acknowledges the obligation to pay all self-employment and other taxes thereon and that he will not be eligible for any employee benefits (nor does he desire any of them) and expressly waives any entitlement to such benefits. Consultant acknowledges and agrees that he will use his own discretion in performing the tasks assigned, within the scope of work specified by the Company. Except insofar as it would preclude the Consultant from providing the Services under this Agreement, Consultant is free to perform services for any other party.

 

8.                                      EQUITABLE RELIEF

 

Consultant and the Company agree that it would be impossible or inadequate to measure and calculate the Company’s damages from any breach of the covenants set forth in Sections 2 or 3 herein. Accordingly, Consultant and the Company agree that if Consultant breaches Sections 2 or 3, the Company will have available, in addition to any other right or remedy available, the right to obtain from any court of competent jurisdiction an injunction restraining such breach or threatened breach and specific performance of any such provision. Consultant and the Company further agree that no bond or other security shall be required in obtaining such equitable relief and Consultant and the Company, hereby consent to the issuances of such injunction and to the ordering of such specific performance.

 

9.                                      SEVERABILITY

 

If any provision in this Agreement shall be found or be held to be invalid or unenforceable in any jurisdiction in which this Agreement is being performed, then the meaning of said provision shall be construed, to the extent feasible, so as to render the provision enforceable, and if no feasible interpretation would save such provision, it shall be severed from the remainder of this Agreement which shall remain in full force and effect. In such event, the parties shall negotiate, in good faith, a substitute, valid and enforceable provision which most nearly effects the parties’ intent in entering into this Agreement.

 

10.                               NO WAIVER

 

No waiver of any term or condition of this Agreement shall be valid or binding on either party unless the same shall be been mutually assented to in writing by both parties. The failure of either party to enforce at any time any of the provisions of this Agreement, or the failure to require at any time performance by the other party of any of the provisions of this Agreement, shall in no way be construed to be a present or future waiver of such provisions, nor in any way affect the right of either party to enforce each and every such provision thereafter. The express waiver by either party of any provision, condition or requirement of this Agreement shall not constitute a waiver of any future obligation to comply with such provision, condition or requirement.

 

11.                               GOVERNING LAW

 

This Agreement is governed by the laws of the Commonwealth of Massachusetts, notwithstanding principles of conflict of laws.

 

12.                               ASSIGNMENT; ENTIRE AGREEMENT; AMENDMENT

 

This Agreement constitutes the entire agreement between the parties and supersedes any prior negotiation,

 

Portions of this Exhibit, indicated by the mark “[***],” were omitted because the information (i) is not material and (ii) would be competitively harmful if publicly disclosed.

 

4

 

discussions, or understandings with respect to the subject matter hereof. This Agreement may not be amended in any respect other than by written instrument executed by each party. This contact may not be assigned by either party; provided, however that the Company may assign this Agreement in connection with the sale or other disposition of all or a material part of the business to which this Agreement pertains.

 

13.                               COUNTERPARTS

 

This agreement may be executed in one or more facsimile or electronic counterparts each of which shall, when taken together, constitute one and the same original agreement.

 

*** END OF EXHIBIT A ***

 

Portions of this Exhibit, indicated by the mark “[***],” were omitted because the information (i) is not material and (ii) would be competitively harmful if publicly disclosed.

 

5

 

CONSULTING AGREEMENT

Exhibit B — Statement of Work

 

1.              Services.

 

The Services include the following:

 

[***]

 

All services will be performed personally by Jackson Streeter, M.D.

 

2.              Compensation.

 

The Company agrees to pay Consultant a monthly retainer of $12,500 with the expectation that this represents roughly 50% of Consultant’s time.  Consultant will submit to the Company a statement of the services performed for the Company in the previous month.  This fee shall be payable monthly, due within 30 days following the submission of the statement.

 

In addition, the Consultant will be eligible to receive a finder’s fee of up to three percent (3%) of revenues recognized by the Company of the new opportunities for the sale of Quanterix products and services for new opportunities identified by Consultant to Quanterix. To be recognized as a new opportunity, (i) the Consultant must inform the Quanterix Contact of a possible transaction (including the name of the customer, the customer contact information, and a reasonably detailed description of the opportunity) in writing delivered to the Quanterix contact promptly after it is identified by the Consultant and in any case prior to the expiration or termination of this Agreement; (ii) the customer or the opportunity must not have been known to the Company at the time Consultant first informs the Company per (i) above (the “Notification Date”) and which Company had been actively pursuing a sale within ninety (90) days prior to such Notification Date; (iii) the Consultant provides the Company with such additional information and assistance as may to be requested to complete the sale; and (iii) the sale must be completed, and the revenue recognized, within ninety (90) days from the Notification Date. Whether a particular transaction qualified as a new opportunity, and the amount of any finder’s fee to which the Consultant may be entitled, will be as determined by the Quanterix Contact in his or her sole discretion. Any decision as to whether to pursue a new transaction, and the terms of such transaction, will be as determined by the Company in its sole discretion.

 

Consultant’s outstanding restricted stock unit and stock option awards granted November 2018 will continue to vest through the one year anniversary of your start date as a regular full time employee according to the terms and conditions of the applicable award agreements.

 

Portions of this Exhibit, indicated by the mark “[***],” were omitted because the information (i) is not material and (ii) would be competitively harmful if publicly disclosed.

 

6Exhibit

Exhibit 10.2
CAPITAL ONE FINANCIAL CORPORATION
2004 Stock Incentive Plan
Restricted Stock Unit Award Agreement
 
No. of Units:  [# Units]
 
THIS RESTRICTED STOCK UNIT AWARD AGREEMENT (this “Agreement”), dated [Month] [Day], 2019 (the “Date of Grant”), between CAPITAL ONE FINANCIAL CORPORATION, a Delaware corporation (“Capital One” or the “Company”), and [Full NAME] (“you”), is made pursuant and subject to the provisions of the Company’s 2004 Stock Incentive Plan, as amended and restated (the “Plan”).  All capitalized terms used herein that are defined in the Plan shall have the same meaning given them in the Plan unless otherwise defined herein:
 
W I T N E S S E T H :
 
1.     Grant of Restricted Stock Units. Pursuant and subject to the terms and conditions set forth in this Agreement and in the Plan, Capital One hereby grants to you [# Units] Restricted Stock Units (the “Restricted Stock Units”). The Restricted Stock Units shall vest, and the shares of common stock of the Company, $.01 par value per share (the “Shares”), underlying the Restricted Stock Units shall be issuable, only in accordance with the provisions of this Agreement and of the Plan. The Restricted Stock Units will not have voting rights.
 
2.     Non-Transferability. Subject to the provisions of Section 3 hereof, the rights represented by the Restricted Stock Units and the underlying Shares related thereto shall not be assignable or transferable, or otherwise alienated or pledged or hypothecated or otherwise encumbered under any circumstances.  Any purported or attempted assignment, transfer, alienation, pledge, hypothecation or encumbrance of the Restricted Stock Units or the underlying Shares related thereto prior to their issuance to you shall be null and void and shall result in the immediate forfeiture of such Restricted Stock Units, including the underlying Shares, and cancellation of this Agreement.
 
3.     Issuance of Common Stock.
 
(a)     Vesting. Except as provided in Section 3(b) below, all Restricted Stock Units shall, to the extent not previously vested or forfeited as provided herein, vest on the first anniversary of the Date of Grant (the “Vesting Date”); provided, however, that the underlying Shares shall not be issued to you or be assignable or transferable by you until the date of termination of your service as a Director of the Company (the “Termination Date”), as provided in Section 3(b) below.

The vesting of the Restricted Stock Units and the issuance of the underlying Shares shall be subject to Sections 6 through Section 9 of this Agreement.
 
(b)     Effect of Termination of Service. Upon your termination of service as a Director of the Company for any reason other than by removal for cause, all Restricted Stock Units shall, to the extent not previously vested or forfeited as provided herein, immediately vest, and the underlying Shares shall immediately be issuable to you in full without restrictions on transferability.  Upon your termination of service as a Director by removal for cause, all Restricted Stock Units and the underlying Shares, including any Shares accrued in connection with the payment of dividends as provided in Section 5 below, shall immediately be forfeited, whether or not previously vested. 
 
4.     Modification and Waiver. Except as provided in the Plan with respect to determinations of the Board of Directors or the Committee and subject to the Committee’s right to amend the Plan, neither this Agreement nor any provision hereof can be changed, modified, amended, discharged, terminated or waived orally or by any course of dealing or purported course of dealing, but only by an agreement in writing signed by you and the Company; provided that changes, modifications and amendments not detrimental to you may be made in writing signed only by the Company. No such agreement shall extend to or affect any provision of this Agreement not expressly changed, modified, amended, discharged, terminated or waived or impair any right consequent on such a provision. The waiver of or failure to enforce any breach of this Agreement shall not be deemed to be a waiver or acquiescence in any other breach thereof.

5.     Dividends.  Dividends with respect to the Restricted Stock Units shall accrue beginning on the Date of Grant through the Termination Date, at which time such accrued dividends shall be paid out in the form of additional Shares based on the Fair Market Value of a share of the Company’s common stock on the business day prior to the Termination Date.  The accrued dividends that shall be paid out to you shall be only such amount that has accrued with respect to the underlying Shares that vest on the Vesting Date or as described in Section 3(b) above.  

6.     Governing Law. This Agreement shall be governed by United States federal law and, to the extent not preempted thereby, by the laws of the State of Delaware. Capital One and you hereby consent and submit to the personal jurisdiction and venue of any state or federal court located in any city or county of Delaware for resolution of any and all claims, causes of action or disputes arising out of this Agreement.  You and Capital One agree that the court shall not set aside the Committee’s determinations unless there is clear and convincing evidence of bad faith or fraud.
 
7.     Conflicts. In the event of any conflict between the provisions of the Plan as in effect on the Date of Grant and the provisions of this Agreement, except terms otherwise defined herein, the provisions of the Plan shall govern. All references herein to the Plan shall mean the Plan as in effect on the date hereof.
 
8.     Bound by Plan. In consideration of this grant of Restricted Stock Units, you agree that you will comply with such conditions as the Board of Directors and the Committee may impose on the Restricted Stock Units and be bound by the terms of the Plan.
 
9.     Binding Effect. This Agreement shall be binding upon, enforceable against and inure to the benefit of you and your legatees, distributees and personal representatives, and the Company and its successors and assigns.
 
10.    Miscellaneous.  In accepting the grant, you acknowledge and agree that:

(a)    this Agreement is intended to comply with the applicable requirements of Section 409A of the Code and shall be limited, construed and interpreted in a manner so as to comply therewith;

(b)    your obligations under this Agreement shall survive any termination of your service for any reason;

(c)    Any of the Company’s rights or remedies under this Agreement shall be cumulative and in addition to whatever other remedies the Company may have under law or equity;

(d)    the Company may, to the maximum extent permitted by applicable law and Section 409A of the Code, retain for itself funds or securities otherwise payable to you pursuant to this Agreement to satisfy any obligation or debt that you owe the Company, including any obligations hereunder.  The Company may not retain such funds or securities until such time as they would otherwise be distributable to you in accordance with this Agreement;

(e)    the Company reserves the right to impose other requirements on the Restricted Stock Units, any Shares acquired pursuant to the Restricted Stock Units, and your participation in the Plan, to the extent Capital One determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local laws, rules and regulations, or to facilitate the administration of the Restricted Stock Units and the Plan.  Such requirements may include (but are not limited to) requiring you to sign any agreements or undertakings that may be necessary to accomplish the foregoing; and

(f)    Capital One from time to time distributes and makes available disclosure documents, including a prospectus, relating to the Plan.  You may also contact the HR Help Center to obtain copies of the Plan disclosure documents and the Plan. You represent that you are familiar with the terms of the Plan and have had the opportunity to ask questions and receive answers concerning the terms and conditions of the Restricted Stock Units. As a condition of this award and your right to receive Restricted Stock Units and the underlying Shares, you must accept this Agreement. By doing so, you confirm the accuracy of the statement set forth in the third sentence of this paragraph, acknowledge receipt of the Plan and the Plan disclosure documents and evidence your acceptance of and agreement to be bound by the terms of this Agreement and the Plan.

 
IN WITNESS WHEREOF, CAPITAL ONE FINANCIAL CORPORATION has caused this Agreement to be signed on its behalf.
 
CAPITAL ONE FINANCIAL CORPORATION

/s/ Mayo Shattuck III
Mayo Shattuck III
Chair, Compensation Committee

PARTICIPANT

By: SIGNED BY ELECTRONIC SIGNATURE
[Full Name]

BY ELECTRONICALLY ACCEPTING THE AWARD, YOU AGREE THAT (i) SUCH ACCEPTANCE CONSTITUTES YOUR ELECTRONIC SIGNATURE IN EXECUTION OF THIS AGREEMENT; (ii) YOU AGREE TO BE BOUND BY THE PROVISIONS OF THE PLAN AND THE AGREEMENT; (iii) YOU HAVE REVIEWED THE PLAN AND THE AGREEMENT IN THEIR ENTIRETY, HAVE HAD AN OPPORTUNITY TO OBTAIN THE ADVICE OF COUNSEL PRIOR TO ACCEPTING THE AWARD AND FULLY UNDERSTAND ALL OF THE PROVISIONS OF THE PLAN AND THE AGREEMENT; (iv) YOU HAVE BEEN PROVIDED WITH A COPY OR ELECTRONIC ACCESS TO A COPY OF THE U.S. PROSPECTUS FOR THE PLAN; AND (v) YOU HEREBY AGREE TO ACCEPT AS BINDING, CONCLUSIVE AND FINAL ALL DECISIONS OR INTERPRETATIONS OF THE COMMITTEE UPON ANY QUESTIONS ARISING UNDER THE PLAN AND THE AGREEMENT.

*          *          *         *          *

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}]]